Clinical Trial Update: Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for ORACEA in geographic atrophy (Phase 2/3) is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• ORACEA (Doxycycline)

Snippet

Sponsor: Paul Yates, MD, PhD | Conditions: Geographic Atrophy | Phase 2, Phase 3 | Status: COMPLETED